Olema Pharmaceuticals share price logo

Olema Pharmaceuticals

NASDAQ: OLMA

Small Cap

$8.75

-0.29

(-3.21%)

as on

Olema Pharmaceuticals Stock Performance

as on September 26, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $8.57
    $9.04
    downward going graph

    2.06%

    Downside

    3.31%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $6.65
    $36.26
    downward going graph

    24.00%

    Downside

    314.39%

    Upside

    downward going graph

Olema Pharmaceuticals share price movements today

Previous Close
$9.04
Open
$9.04
Volume
1.8M
Market Cap
$791.0M
Day's Low - High
$8.57 - $9.04
52 Week Low - High
$6.65 - $36.26

Olema Pharmaceuticals Historical Returns

1 Month Return
-19.35 %
3 Month Return
-23.18 %
1 Year Return
-7.99 %
3 Year Return
-31.96 %
5 Year Return
-69.27 %

Olema Pharmaceuticals Stock Fundamentals & Key Indicators

Check Olema Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$791.0M

EPS (TTM)

-2.12

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-4.26

Industry PE ratio

-8.07

PEG Ratio

0.832562738810856

EBITDA

-204.0M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-48.22%

Olema Pharmaceuticals Stock Valuation

Track how Olema Pharmaceuticals P/E has moved over time to understand its valuation trends.

Olema Pharmaceuticals in the last 5 years

  • Overview

  • Trends

Lowest (-13.37x)

December 31, 2025

Today (-13.37x)

December 31, 2025

Industry (-8.07x)

December 31, 2025

Highest (-0.94x)

December 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -13.37x

Olema Pharmaceuticals vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Olema Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$791.0M-69.27%-4.260.00%0.00%
Neutral$77.8B-53.76%-24.41-12.57%0.00%
StrongBuy$132.4B186.58%30.1686.04%0.00%
Buy$82.8B23.34%19.0184.86%0.46%

Stock Returns calculator for Olema Pharmaceuticals Stock including INR - Dollar returns

The Olema Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Olema Pharmaceuticals investment value today

Current value as on today

₹99,311

Returns

-₹689

(-0.69%)

Returns from Olema Pharmaceuticals Stock

-₹7,992 (-7.99%)

Dollar Impact

₹7,302 (+7.3%)

Analyst Recommendation on Olema Pharmaceuticals Stock

Based on 7 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 7 analysts, 100% of analysts recommend a 'BUY' rating for Olema Pharmaceuticals. Average target price of $36.5

Olema Pharmaceuticals Share Price Target

Get share price movements and forecasts by analysts on Olema Pharmaceuticals.

What analysts predicted

76.03%UPSIDE

Target Price

$36.5

Current Price

$8.75

Analyzed by

7 Analysts

High

$59

Target

$36.50

Low

$16

Olema Pharmaceuticals target price $36.5, a slight upside of 76.03% compared to current price of $8.75. According to 7 analysts rating.

Indian Investors' Interest in Olema Pharmaceuticals Stock

Search interest for Olema Pharmaceuticals Stock has decreased by -56% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-56% versus previous 30 day period

Olema Pharmaceuticals Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
0
0
-
Operating Income
-34
-33
-37
-36
-34
-47
-45
-50
-57
-67
EBITDA
-30
-30
-34
-33
-30
-43
-42
-45
-52
-62
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-30
-30
-34
-33
-30
-43
-42
-46
-53
-63
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-30
-30
-34
-33
-30
-43
-42
-46
-53
-63
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Olema Pharmaceuticals Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
-
-
-
-
-
Operating Income
-2
-4
-21
-71
-106
-104
-142
-178
EBITDA
-2
-4
-21
-70
-104
-96
-129
-161
Interest Expense
0
-
0
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
Income Before Tax
-2
-4
-22
-71
-104
-96
-129
-162
Income Tax Expense
-
-
-
-
-
-
-
-
Net Income
-2
-4
-22
-71
-104
-96
-129
-162
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Olema Pharmaceuticals Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-30
-30
-34
-33
-30
-43
-42
-46
-53
-63
Operating Cash Flow
-23
-27
-27
-26
-43
-29
-34
-38
-45
-45
Investing Cash Flow
-20
-4
45
-114
-45
34
17
-162
4
40
Financing Cash Flow
8
15
0
244
0
-2
0
213
45
1
Change in Cash
-34
-16
18
103
-88
1
-17
13
4
-3

Olema Pharmaceuticals Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-2
-4
-22
-71
-104
-96
-129
-162
Operating Cash Flow
-2
-3
-19
-50
-82
-83
-104
-146
Investing Cash Flow
-
-
0
-275
91
-4
-93
-155
Financing Cash Flow
5
-
358
1
0
133
268
211
Change in Cash
3
-3
338
-324
9
44
70
-91

Mutual Funds that own Olema Pharmaceuticals Stock

Check out the Mutual Funds with significant holdings in Olema Pharmaceuticals.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
3.437652%
3007864
Fidelity Select Portfolios
2.335035%
2043100
Fidelity Securities Fund
1.817764%
1590500
Fidelity Advisor Series VII
1.745419%
1527200
Fidelity Concord Street Trust
1.355218%
1185784

Global Institutional Holdings in Olema Pharmaceuticals

Funds
Holdings
Vanguard
4.54%
iShares
4.45%
VANGUARD INDEX FUNDS
3.44%
Peter Kolchinsky
2.97%
SPDR
2.9%

Olema Pharmaceuticals News & Key Events

  • img

    Today's Timeline - 14 September

    Mon, 03:50 PM

    -

    JPMorgan maintains Overweight rating on Olema after AstraZeneca's SERENA-4 trial missed significance, viewing selloff as overreaction.

Insights on Olema Pharmaceuticals

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 102.7% return, outperforming this stock by 134.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 712.1% return, outperforming this stock by 720.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, OLMA stock has moved down by -10.9%

About Olema Pharmaceuticals

Olema Pharmaceuticals, Inc., a biopharmaceutical enterprise in the clinical development stage, is dedicated to discovering, advancing, and commercializing therapeutic solutions for women's oncology. Headquartered in San Francisco, California, the company was established in 2006 and rebranded from CombiThera, Inc. in March 2009. Its most promising investigational compound, OP-1250, an estrogen receptor (ER) antagonist and selective ER degrader, is presently undergoing Phase 1/2 clinical evaluations. This drug candidate is being assessed for its efficacy in managing recurrent, locally advanced, or metastatic breast cancer that expresses estrogen receptors but is negative for human epidermal growth factor receptor 2.
OrganisationOlema Pharmaceuticals
Headquarters780 Brannan Street, San Francisco, CA, 94103, US
IndustryBiotechnology
CEOSean Bohen
E-voting on sharesClick here to vote

Key Management of Olema Pharmaceuticals

Name

Title

Dr. Naseem Zojwalla M.D.

Chief Medical Officer

Dr. Kamesh Kuchimanchi Ph.D.

Senior Vice President of Regulatory Affairs & Quality Assurance

Dr. Sean P. Bohen M.D., Ph.D.

President, CEO & Director

Ms. Shawnte M. Mitchell J.D.

Chief Legal Officer & Corporate Secretary

Ms. Courtney O'Konek

Vice President of Corporate Communications

Ms. Julie Dexter

Senior VP & Head of People

Mr. Richard Hernandez

Senior Vice President of Clinical Development Operations

Dr. Mark Shilkrut M.D., Ph.D.

Senior Vice President of Clinical Development

Mr. Jason O'Byrne M.B.A.

CFO, Principal Financial Officer & Accounting Officer

Dr. David C. Myles Ph.D.

Chief Scientific Officer

FAQs

What is Olema Pharmaceuticals share price today?

Olema Pharmaceuticals share price today is $8.75 as on at the close of the market. Olema Pharmaceuticals share today touched a day high of $9.04 and a low of $8.57.

What is the 52 week high and 52 week low for Olema Pharmaceuticals share?

Olema Pharmaceuticals share touched a 52 week high of $36.26 on and a 52 week low of $6.65 on . Olema Pharmaceuticals stock price today i.e. is closed at $8.75,which is 75.87% down from its 52 week high and 31.58% up from its 52 week low.

What is Olema Pharmaceuticals's market capitalisation today?

Olema Pharmaceuticals market capitalisation is $0.00T as on .

How to invest in Olema Pharmaceuticals Stock (OLMA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Olema Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Olema Pharmaceuticals Shares that will get you 0.1714 shares as per Olema Pharmaceuticals share price of $8.75 per share as on September 26, 2026 at 8:45 am IST.

What is the minimum amount required to buy Olema Pharmaceuticals Stock (OLMA) from India?

Indian investors can start investing in Olema Pharmaceuticals (OLMA) shares with as little as ₹95.8125 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.13 in Olema Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ). Based on Olema Pharmaceuticals share’s latest price of $8.75 as on September 26, 2026 at 8:45 am IST, you will get 1.1429 shares of Olema Pharmaceuticals. Learn more about fractional shares .

What are the returns that Olema Pharmaceuticals has given to Indian investors in the last 5 years?

Olema Pharmaceuticals stock has given -69.27% share price returns and 29.49% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?